PGL prospa group limited.

latest bell potter research , page-4

  1. 580 Posts.
    Nexavar is the sort of competition that biotech investors have nightmares about. The market can't ignore this threat for much longer, and a share price of $2 isn't out of the question.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.